West Pharmaceutical Services, Inc.

WSTNYSE • USD
ThemeMedical Devices & HealthTech›Diagnostic Imaging & Equipment
318.69 USD
↗ 2.27 (0.72%)🟢LIVE (AS OF 11:08 AM EDT)
🟢Market: OPEN
Open?$318.60
High?$320.68
Low?$314.90
Prev. Close?$316.42
Volume?63.6K
Avg. Volume?921.9K
VWAP?$318.39
Rel. Volume?0.07x
Bid / Ask
Bid?$318.98 × 100
Ask?$319.62 × 100
Spread?$0.64
Midpoint?$319.30
Valuation & Ratios
Market Cap?22.4B
Shares Out?70.6M
Float?71.6M
Float %?99.4%
P/E Ratio?41.19
P/B Ratio?7.48
EPS?$7.68
Dividend?0.28%
Ex-Dividend?N/A

West Pharmaceutical Services, Inc. (WST) is currently trading at $318.69. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Key drivers include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, WST is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of May 26, 2026.

RelatedEHCCHE
News
Profile
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Themes
Medical Devices & HealthTech›Diagnostic Imaging & EquipmentBiotech - Drug Development›Clinical-Stage Platforms
Employees
10.8K
Market Cap
22.4B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.westpharma.com
Listed
1973-01-02
Address
530 HERMAN O. WEST DRIVE
EXTON, PA 19341
Phone: (610) 594-2900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
96
Short Sent.?
80
Piotroski F-Score?6/9Mixed
Altman Z-Score?15.18Safe
Confidence?80%High
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.39%Low
Short Interest?2.4M
Days to Cover?2.1
Free Float71.6M
Avg Daily Volume1.2M
Settlement Date2026-04-30
Financial Health
Current Ratio?2.71Strong
Quick Ratio?2.04Strong
Cash Ratio?0.77Adequate
Debt/Equity?0.07Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
44/100
P/E?
Peers
33
S&P
17
41.2PRICEY▾
P/B?
Peers
33
S&P
25
7.48FAIR▾
P/S?
Peers
33
S&P
17
6.94FAIR▾
P/FCF?
Peers
33
S&P
10
48.8PRICEY▾
EV/EBITDA?
Peers
33
S&P
15
25.4HIGH▾
EV/Sales?
Peers
33
S&P
21
6.84HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
62
18.2%STRONG▾
ROA?
Peers
67
S&P
83
13.2%STRONG▾
Cash Flow & Enterprise
FCF?$458.0M
Enterprise Value?$22.0B
Fundamentals ratios updated end of day
MarketsMoversWatchlist